Implication de la mutation A224D du récepteur de facteur activateur des plaquettes dans la susceptibilité à la forme rémittente de la sclérose en plaques : étude d’une population tunisienne

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pathologie Biologie

• Publication date

  2012-06-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.PATBIO.2011.04.004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules.

  2008cited by this paper
• DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS OF MULTIPLE SCLEROSIS

  2007cited by this paper
• Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis.

  2005cited by this paper
• Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination

  2003cited by this paper
• Platelet-activating factor receptor.

  2002cited by this paper
• Platelet-activating Factor, a Molecular Sensor for Cellular Damage, Activates Systemic Immune Suppression

  2002cited by this paper
• Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

  2002cited by this paper
• Single Nucleotide Polymorphism of Human Platelet-activating Factor Receptor Impairs G-protein Activation*

  2001cited by this paper
• Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells.

  2000cited by this paper
• Role of platelet-activating factor in cardiovascular pathophysiology.

  2000cited by this paper
• Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis.

  1999cited by this paper
• The Natural History of Multiple Sclerosis: Update 1998

  1998cited by this paper
• Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.

  1998cited by this paper
• Predominant Expression of Platelet-Activating Factor Receptor in the Rat Brain Microglia

  1996cited by this paper
• IL‐3 derived from CD4+ T cells is essential for the in vitro expansion of mast cells from the normal adult mouse spleen

  1996cited by this paper
• Platelet-activating factor: receptors and signal transduction.

  1993cited by this paper
• Possible induction of intercellular adhesion molecule-1 (ICAM-1) expression on endothelial cells by platelet-activating factor (PAF).

  1992cited by this paper
• Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung

  1991cited by this paper
• Acetylcholine‐induced production of platelet‐activating factor by human fetal brain cells in culture

  1990cited by this paper
• The de novo biosynthesis of platelet-activating factor in rat brain.

  1989cited by this paper
• Production and effects of platelet-activating factor in the rat brain.

  1988cited by this paper
• MHC in central nervous system: modulation of expression by PAF-acether

  1987cited by this paper
• Production of platelet-activating factor by chick retina.

  1986cited by this paper
• Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

  1986cited by this paper
• 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants.

  1981cited by this paper
• LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS

  1972cited by this paper

• Association of platelet-activating factor receptor gene rs5938 (G/T) and rs313152 (T/C) polymorphisms with coronary heart disease and blood stasis syndrome in a Chinese Han population

  2017cites this paper
• Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.

  2016cites this paper
• Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study

  2014cites this paper